GlassScriptPhysician profile
Kelly Weitz
NPI 1881932481
$2,834.60
in general payments reported to CMS, 2019-2025
35 companies · $558 in 2025
The $558 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $678 · 2022: $447 · 2023: $499 · 2024: $653 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,709.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $510.90 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $503.42 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $294.48 | 2021-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $241.28 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $125.81 | 2021-2025 | Repatha, Otezla |
| Gilead Sciences, INC. | $103.97 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $73.03 | 2021-2023 | Fanapt, Hetlioz |
| Abbott Laboratories | $68.96 | 2024 | Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $65.27 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $62.55 | 2025 | Caplyta |
| Bausch Health US, LLC | $58.11 | 2022 | |
| Exact Sciences Corporation | $56.55 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.97 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $51.02 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $50.74 | 2023-2025 | Rexulti |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $43.50 | 2021-2022 | |
| Glaxosmithkline, LLC. | $42.47 | 2025 | Shingrix, Arexvy, Bexsero |
| Vyera Pharmaceuticals, LLC | $35.84 | 2021 | |
| Medtronic, INC. | $34.47 | 2023 | Intellis Adaptivestim |
| Organon LLC | $33.36 | 2022 | |
| Viiv Healthcare Company | $31.18 | 2024 | Apretude |
| Phadia US INC. | $28.72 | 2021 | |
| Antares Pharma, INC. | $27.84 | 2021-2022 | |
| Amarin Pharma, INC. | $23.50 | 2021 | |
| Boston Scientific Corporation | $23.41 | 2023 | |
| Exeltis, USA INC. | $23.40 | 2023 | Slynd |
| Biohaven Pharmaceuticals, INC. | $23.36 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.18 | 2021 | |
| Axsome Therapeutics, INC. | $21.81 | 2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.53 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $19.36 | 2023 | Opsumit |
| Sanofi-Aventis U.S. LLC | $17.98 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.58 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.28 | 2022 | |
| Biodelivery Sciences International, INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Weitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.